← Back to Search

Procedure

Supportive Care (GA-guided intervention) for Breast Cancer

N/A
Recruiting
Led By Meghan Karuturi, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year.
Awards & highlights

Study Summary

This trial looks at how geriatric assessment and visits after treatment can improve the health of older adults with breast cancer. It could improve their well-being and quality of life.

Who is the study for?
This trial is for older adults who are at least 65 years old and have recently completed treatment for early-stage breast cancer (Stage I-III). They must be able to consent, speak English or Spanish, and meet all study requirements. Caregivers can also participate if they're over 18. People with significant medical conditions that prevent exercise participation cannot join.Check my eligibility
What is being tested?
The trial is testing a geriatric care survivorship intervention aimed at improving health in elderly patients post-breast cancer treatment. It includes comprehensive assessments of physical and mental health, usage of medical devices, health education, and supportive care to enhance quality of life.See study design
What are the potential side effects?
Since the interventions involve non-invasive procedures like assessments and educational support rather than medications or surgeries, side effects are minimal but may include discomfort from discussions about personal health issues or fatigue from assessment activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional Assessment of Cancer Therapy-Breast (FACT-B) questionnaires

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Care (GA-guided intervention)Experimental Treatment4 Interventions
Patients complete geriatric assessments at baseline, 6 months, and 12 months later. Based on the assessments, patients may receive further intervention at survivorship visit. Patients also receive survivorship care educational materials and wear a wearable activity tracking device for 1 year on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4010

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,974 Previous Clinical Trials
1,789,446 Total Patients Enrolled
148 Trials studying Breast Cancer
63,286 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,669 Previous Clinical Trials
40,926,371 Total Patients Enrolled
940 Trials studying Breast Cancer
1,543,360 Patients Enrolled for Breast Cancer
Meghan Karuturi, MDPrincipal InvestigatorM.D. Anderson Cancer Center
2 Previous Clinical Trials
27 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applicants being accepted for participation in this investigation?

"Per the information on clinicaltrials.gov, this trial is still searching for willing participants as of 6/23/2023; it was first posted to the platform two years prior, on 6/17/2021."

Answered by AI

How many individuals can potentially join this research endeavor?

"Affirmative. According to clinicaltrials.gov, this medication trial is currently recruiting patients who meet the inclusion criteria; it was introduced on June 17th 2021 and last updated on June 23rd 2023. 30 participants are required from one medical centre for successful completion of the study protocol."

Answered by AI
~6 spots leftby Dec 2024